Home > COVID-19 vaccine patents: EU ‘ready to discuss’ lifting intellectual property rights

News
COVID-19 vaccine patents: EU ‘ready to discuss’ lifting intellectual property rights

Description

Commission president von der Leyen said the bloc would discuss the move, after the US said it backed plans which poorer countries hope would speed up the development and production of coronavirus vaccines.

Added on the 06/05/2021 06:55:00 - Copyright : Euronews EN

To customise your video :

Or Create an account

More videos on the subject

  • Organizations demand in Brussels the lifting of patents for Covid-19 vaccine

    Brussels, Apr 7 (EFE) .- (Camera: Leopoldo Rodríguez) Several organizations gathered Wednesday in front of the headquarters of the European institutions in Brussels to demand, on the ocassion of the World Health Day, the lifting of patents of vaccines against Covid-19 by pharmaceutical companies that, according to protesters, generates an unequal distribution in access among countries.FOOTAGE OF THE CONCENTRATION IN BRUSSELS (BELGIUM) TO DEMAND THE LIFTING OF THE PATENTS OF THE VACCINES AGAINST COVID-19 BY THE PHARMACEUTICALS. SOUNDBITES OF RICARDO PETRELLA.

    07/04/2021 - EFE Inglés
  • EU ready to 'discuss' Covid vaccine patent waivers

    European Commission President Ursula von der Leyen says that Brussels is ready to discuss a US-backed proposal to waive patents on Covid-19 vaccines. SOUNDBITE

    06/05/2021 - AFPTV - First images
  • Iran says local Covid-19 vaccine could be ready in spring 2021

    Tehran (Iran), Dec 22 (EFE / EPA), (Camera: Abedin Taherkenareh).- Iranians complain that the country's government has not yet requested the Covid-19 vaccine to any foreign country. According to local media, Iranian authorities have announced that the locally manufactured vaccine could be ready in spring 2021. FOOTAGE OF TEHRAN.

    22/12/2020 - EFE Inglés
  • FDA To Discuss Emergency Authorization For Pfizer COVID-19 Vaccine

    An FDA advisory committee will meet next month to discuss an emergency use authorization. The emergency use authorization would be for Pfizer's COVID-19 vaccine. Earlier this week, Pfizer said clinical trials had shown its vaccine to be 95% effective. "While we cannot predict how long the FDA's review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner," FDA Commissioner Stephen M. Hahn In October, the Emergency Care Research Institute warned against releasing a vaccine. They said six months of follow-up data on clinical trial participants is needed to move forward.

    22/11/2020 - Wochit
  • Anti-vaccine protesters march against Covid-19 mandates in Washington, DC

    Thousands of demonstrators from across the US march in Washington, DC, to decry Covid-19 mandates. Mostly maskless, the protesters walk from the Washington Monument to the Lincoln Memorial in a city that has adopted mask and vaccine mandates. IMAGES

    23/01/2022 - AFPTV - First images
  • Nurse arrested in Palermo, pretends to administer Covid-19 vaccine to patients

    A nurse was arrested in Palermo, Sicily, for pretending to administer a Covid-19 vaccine to consenting patients, in particular to two spouses. In the video surveillance images, the nurse empties the content of a syringe into a gauze before giving the injection. IMAGES

    17/01/2022 - AFPTV - First images

More videosNews

Watch video of  - DemainEntreprendre - épisode 12 - Label : Economie wallonne -
News

DemainEntreprendre - épisode 12

29/04/2021 12:55:32